Highlights

  • Novavax's vaccine gets approved for children
  • Novavax: vaccine was 80% effective against Covid-19
  • In India, Covovax is manufactured by Serum Institute of India.

Latest news

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

Future Netwings Solution Enhances Service Delivery with the Business Continuity Policy

India-UK trade deal likely by May 1; Europe deal expected by year-end

India-UK trade deal likely by May 1; Europe deal expected by year-end

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

VerSe Innovation Appoints Prasanna Prasad as Chief Product and Technology Officer to Accelerate AI-Led Product and Platform Innovation

Changing Aspirations of Premium Homebuyers in NCR

Changing Aspirations of Premium Homebuyers in NCR

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Airfloa Rail Technology's FY26 Business Update and Strategic Direction

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Sanjay Khanna Appointed as Chairman & Managing Director of BPCL

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

Galgotias University Placement Report: 4700+ Offers Across Top Recruiters in 2026

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

"Be the same loving brother you are to me...": Sanjay Dutt pens heartfelt birthday note for Anant Ambani

Covovax gets emergency use approval for children aged 12-17 in India

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

Covovax gets emergency use approval for children aged 12-17 in India

American biotechnology company Novavax has said that its Covid-19 vaccine has got emergency use authorisation for children in 12-17 years age group by India's drug regulator.

The company has claimed that its vaccine produced an immune response in the same age group in a mid- to late-stage study involving 460 Indian adolescents.

Last month Novavax had said its vaccine was 80% effective against Covid-19 in a late-stage trial testing the shot in 2,247 children aged 12 to 17 years.

The vaccine is manufactured in India by Serum Institute of India under the name of Covovax

Also watch: Covovax Explained: Adding another weapon to India's Covid arsenal

Covovax is the fourth Covid-19 vaccine to be authorised for adolescents aged 12 years and older in India after Biological E's Corbevax, Zydus Cadila's ZyCoV-D and Bharat Biotech's Covaxin.

ADVERTISEMENT

Up Next

Covovax gets emergency use approval for children aged 12-17 in India

Covovax gets emergency use approval for children aged 12-17 in India

Union minister says India's Covid vaccine programme more advanced than USA's

Union minister says India's Covid vaccine programme more advanced than USA's

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid-19: minor drop in cases, deaths across India in 24 hours

Covid: India's daily new infections, active cases decline

Covid: India's daily new infections, active cases decline

Covid: India's active cases decline after nearly 70 days

Covid: India's active cases decline after nearly 70 days

Covid 19: India records 12,193 cases in last 24 hours

Covid 19: India records 12,193 cases in last 24 hours

ADVERTISEMENT

editorji-whatsApp

More videos

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Covid surge: Centre asks states to keep strict vigil, take pre-emptive action

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Tripura makes covid test mandatory for people arriving from states with high positivity rate

Covid: India sees slower rise in daily cases; 27 deaths in one day

Covid: India sees slower rise in daily cases; 27 deaths in one day

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Delhi adds 1,396 Covid cases, positivity rate mounts to 31.9 per cent

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid entering endemic stage in India, cases likely to subside after 10-12 days

Covid: USA ends 'national emergency' after over 3 years

Covid: USA ends 'national emergency' after over 3 years

Nationwide Covid-19 drills begin to assess preparedness as cases surge

Nationwide Covid-19 drills begin to assess preparedness as cases surge

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

'The reason could be...': Indian Medical Association on surge in Covid-19 cases

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Covid cases likely to rise in the coming days, says Delhi health minister Saurabh Bhardwaj

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Battling long-Covid, this US woman smelled coffee after over 2 years | Watch her 1st reaction

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.